Selected research
Industry Research
Chronic Refractory Cough (CRC) Treatment Industry Research Report 2026
Market perspective
The global Chronic Refractory Cough (CRC) Treatment market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
North America: the Chronic Refractory Cough (CRC) Treatment market is projected to increase from US$ million in 2026 to US$ million by 2032, reflecting a CAGR of % over 2026–2032. Europe: the Chronic Refractory Cough (CRC) Treatment market is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032. Asia Pacific: the Chronic Refractory Cough (CRC) Treatment market is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032. Leading global service providers of Chronic Refractory Cough (CRC) Treatment include Shionogi, Merck, Respivant Sciences, Nerre Therapeutics, Bellus Health and Attenua, among others; in 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
Read the full market overview
This report quantifies the global Chronic Refractory Cough (CRC) Treatment market in terms of revenue (US$ million) and, where applicable, service volume (K Units), using 2024 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of service Types and end-use Applications, harmonizes provider attribution, and delivers comparable time series by company, Type, Application, and region or country, including indicative price bands (US$/K Units) and concentration ratios (CR5/CR10). Outputs are intended to support service design, budgeting, capacity planning, and benchmarking for providers, platforms, channel partners, and investors; the report also reviews technology shifts and notable service innovations relevant to Chronic Refractory Cough (CRC) Treatment.
Key Companies & Market Share Insights
This section profiles leading service providers with 2021–2025 results and a 2026–2032 outlook—covering revenue, market share, price bands, service portfolio and client mix, regional and channel mix, and key developments (M&A, network expansion, certifications). It also provides global revenue, average price, and—where applicable—volume metrics by provider, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Chronic Refractory Cough (CRC) Treatment Market by Company
Shionogi
Merck
Respivant Sciences
Nerre Therapeutics
Bellus Health
Attenua
Chronic Refractory Cough (CRC) Treatment Segment by Type
Speech Therapy
Physiotherapy
Chronic Refractory Cough (CRC) Treatment Segment by Application
Hospital
Clinic
Others
Chronic Refractory Cough (CRC) Treatment Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Spain
Russia
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Saudi Arabia
Israel
United Arab Emirates
Turkey
Iran
Egypt
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Chronic Refractory Cough (CRC) Treatment market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Chronic Refractory Cough (CRC) Treatment and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Chronic Refractory Cough (CRC) Treatment.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 6: Detailed analysis of Chronic Refractory Cough (CRC) Treatment companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, South America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 13: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Speech Therapy
- Physiotherapy
Applications
- Hospital
- Clinic
- Others
Companies covered
- Shionogi
- Merck
- Respivant Sciences
- Nerre Therapeutics
- Bellus Health
- Attenua
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Chronic Refractory Cough (CRC) Treatment by Type
- 2.2.1 Market Value Comparison by Type (2021 VS 2025 VS 2032)
- 2.2.2 Speech Therapy
- 2.2.3 Physiotherapy
- 2.3 Chronic Refractory Cough (CRC) Treatment by Application
- 2.3.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.3.2 Hospital
- 2.3.3 Clinic
- 2.3.4 Others
- 2.4 Assumptions and Limitations
3 Chronic Refractory Cough (CRC) Treatment Breakdown Data by Type
- 3.1 Global Chronic Refractory Cough (CRC) Treatment Historic Market Size by Type (2021-2026)
- 3.2 Global Chronic Refractory Cough (CRC) Treatment Forecasted Market Size by Type (2027-2032)
4 Chronic Refractory Cough (CRC) Treatment Breakdown Data by Application
- 4.1 Global Chronic Refractory Cough (CRC) Treatment Historic Market Size by Application (2021-2026)
- 4.2 Global Chronic Refractory Cough (CRC) Treatment Forecasted Market Size by Application (2027-2032)
5 Global Growth Trends
- 5.1 Global Chronic Refractory Cough (CRC) Treatment Market Perspective (2021-2032)
- 5.2 Global Chronic Refractory Cough (CRC) Treatment Growth Trends by Region
- 5.2.1 Global Chronic Refractory Cough (CRC) Treatment Market Size by Region: 2021 VS 2025 VS 2032
- 5.2.2 Chronic Refractory Cough (CRC) Treatment Historic Market Size by Region (2021-2026)
- 5.2.3 Chronic Refractory Cough (CRC) Treatment Forecasted Market Size by Region (2027-2032)
- 5.3 Chronic Refractory Cough (CRC) Treatment Market Dynamics
- 5.3.1 Chronic Refractory Cough (CRC) Treatment Industry Trends
- 5.3.2 Chronic Refractory Cough (CRC) Treatment Market Drivers
- 5.3.3 Chronic Refractory Cough (CRC) Treatment Market Challenges
- 5.3.4 Chronic Refractory Cough (CRC) Treatment Market Restraints
6 Market Competitive Landscape by Players
- 6.1 Global Top Chronic Refractory Cough (CRC) Treatment Players by Revenue
- 6.1.1 Global Top Chronic Refractory Cough (CRC) Treatment Players by Revenue (2021-2026)
- 6.1.2 Global Chronic Refractory Cough (CRC) Treatment Revenue Market Share by Players (2021-2026)
- 6.2 Global Chronic Refractory Cough (CRC) Treatment Industry Players Ranking, 2023 VS 2024 VS 2025
- 6.3 Global Key Players of Chronic Refractory Cough (CRC) Treatment Head Office and Area Served
- 6.4 Global Chronic Refractory Cough (CRC) Treatment Players, Product Type & Application
- 6.5 Global Chronic Refractory Cough (CRC) Treatment Manufacturers Established Date
- 6.6 Global Chronic Refractory Cough (CRC) Treatment Market CR5 and HHI
- 6.7 Global Players Mergers & Acquisition
7 North America
- 7.1 North America Chronic Refractory Cough (CRC) Treatment Market Size (2021-2032)
- 7.2 North America Chronic Refractory Cough (CRC) Treatment Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 7.3 North America Chronic Refractory Cough (CRC) Treatment Market Size by Country (2021-2026)
- 7.4 North America Chronic Refractory Cough (CRC) Treatment Market Size by Country (2027-2032)
- 7.5 United States
- 7.5 United States
- 7.6 Canada
- 7.7 Mexico
8 Europe
- 8.1 Europe Chronic Refractory Cough (CRC) Treatment Market Size (2021-2032)
- 8.2 Europe Chronic Refractory Cough (CRC) Treatment Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.3 Europe Chronic Refractory Cough (CRC) Treatment Market Size by Country (2021-2026)
- 8.4 Europe Chronic Refractory Cough (CRC) Treatment Market Size by Country (2027-2032)
- 8.5 Germany
- 8.6 France
- 8.7 U.K.
- 8.8 Italy
- 8.9 Spain
- 8.10 Russia
- 8.11 Netherlands
- 8.12 Nordic Countries
9 Asia-Pacific
- 9.1 Asia-Pacific Chronic Refractory Cough (CRC) Treatment Market Size (2021-2032)
- 9.2 Asia-Pacific Chronic Refractory Cough (CRC) Treatment Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 9.3 Asia-Pacific Chronic Refractory Cough (CRC) Treatment Market Size by Country (2021-2026)
- 9.4 Asia-Pacific Chronic Refractory Cough (CRC) Treatment Market Size by Country (2027-2032)
- 9.5 China
- 9.6 Japan
- 9.7 South Korea
- 9.8 India
- 9.9 Australia
- 9.10 China Taiwan
- 9.11 Southeast Asia
10 South America
- 10.1 South America Chronic Refractory Cough (CRC) Treatment Market Size (2021-2032)
- 10.2 South America Chronic Refractory Cough (CRC) Treatment Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 10.3 South America Chronic Refractory Cough (CRC) Treatment Market Size by Country (2021-2026)
- 10.4 South America Chronic Refractory Cough (CRC) Treatment Market Size by Country (2027-2032)
- 10.5 Brazil
- 10.6 Argentina
- 10.7 Chile
- 10.8 Colombia
- 10.9 Peru
11 Middle East & Africa
- 11.1 Middle East & Africa Chronic Refractory Cough (CRC) Treatment Market Size (2021-2032)
- 11.2 Middle East & Africa Chronic Refractory Cough (CRC) Treatment Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 11.3 Middle East & Africa Chronic Refractory Cough (CRC) Treatment Market Size by Country (2021-2026)
- 11.4 Middle East & Africa Chronic Refractory Cough (CRC) Treatment Market Size by Country (2027-2032)
- 11.5 Saudi Arabia
- 11.6 Israel
- 11.7 United Arab Emirates
- 11.8 Turkey
- 11.9 Iran
- 11.10 Egypt
12 Players Profiled
- 12.1 Shionogi
- 12.1.1 Shionogi Company Information
- 12.1.2 Shionogi Business Overview
- 12.1.3 Shionogi Revenue in Chronic Refractory Cough (CRC) Treatment Business (2021-2026)
- 12.1.4 Shionogi Chronic Refractory Cough (CRC) Treatment Product Portfolio
- 12.1.5 Shionogi Recent Developments
- 12.2 Merck
- 12.2.1 Merck Company Information
- 12.2.2 Merck Business Overview
- 12.2.3 Merck Revenue in Chronic Refractory Cough (CRC) Treatment Business (2021-2026)
- 12.2.4 Merck Chronic Refractory Cough (CRC) Treatment Product Portfolio
- 12.2.5 Merck Recent Developments
- 12.3 Respivant Sciences
- 12.3.1 Respivant Sciences Company Information
- 12.3.2 Respivant Sciences Business Overview
- 12.3.3 Respivant Sciences Revenue in Chronic Refractory Cough (CRC) Treatment Business (2021-2026)
- 12.3.4 Respivant Sciences Chronic Refractory Cough (CRC) Treatment Product Portfolio
- 12.3.5 Respivant Sciences Recent Developments
- 12.4 Nerre Therapeutics
- 12.4.1 Nerre Therapeutics Company Information
- 12.4.2 Nerre Therapeutics Business Overview
- 12.4.3 Nerre Therapeutics Revenue in Chronic Refractory Cough (CRC) Treatment Business (2021-2026)
- 12.4.4 Nerre Therapeutics Chronic Refractory Cough (CRC) Treatment Product Portfolio
- 12.4.5 Nerre Therapeutics Recent Developments
- 12.5 Bellus Health
- 12.5.1 Bellus Health Company Information
- 12.5.2 Bellus Health Business Overview
- 12.5.3 Bellus Health Revenue in Chronic Refractory Cough (CRC) Treatment Business (2021-2026)
- 12.5.4 Bellus Health Chronic Refractory Cough (CRC) Treatment Product Portfolio
- 12.5.5 Bellus Health Recent Developments
- 12.6 Attenua
- 12.6.1 Attenua Company Information
- 12.6.2 Attenua Business Overview
- 12.6.3 Attenua Revenue in Chronic Refractory Cough (CRC) Treatment Business (2021-2026)
- 12.6.4 Attenua Chronic Refractory Cough (CRC) Treatment Product Portfolio
- 12.6.5 Attenua Recent Developments
13 Report Conclusion
14 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst